Related Experiment Videos
Bioactive ent-kaurene diterpenoids from Annona senegalensis
M O Fatope1, O T Audu, Y Takeda
1Department of Chemistry, Bayero University, Kano, Nigeria.
Journal of Natural Products
|March 1, 1996
Summary
Researchers isolated four bioactive ent-kaurenoids from Annona senegalensis stem bark. One compound showed potent breast cancer cell cytotoxicity, while two others demonstrated selective activity against prostate cancer cells.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Annona senegalensis is a plant used in traditional medicine.
- Natural products are a rich source of potential anticancer agents.
- Ent-kaurenoids are a class of diterpenoids with diverse biological activities.
Purpose of the Study:
- To isolate and characterize bioactive compounds from Annona senegalensis stem bark.
- To evaluate the cytotoxic activity of isolated compounds against cancer cell lines.
- To identify novel anticancer leads from natural sources.
Main Methods:
- Activity-guided fractionation of Annona senegalensis stem bark extract.
- Isolation and purification of ent-kaurenoids using chromatographic techniques.
- Cytotoxicity assays using MCF-7 (breast cancer) and PC-3 (prostate cancer) cell lines.
- Structural elucidation of new compounds using spectral data (e.g., NMR, MS).
Main Results:
- Four bioactive ent-kaurenoids (compounds 1-4) were isolated.
- Compound 2 exhibited selective and significant cytotoxicity against MCF-7 breast cancer cells (ED50 1.0 µg/mL).
- Compounds 3 and 4 showed selective cytotoxicity against PC-3 prostate cancer cells (ED50 17-18 µg/mL).
- A new ent-kaurenoid, compound 3, was identified and its structure determined.
Conclusions:
- Annona senegalensis stem bark contains ent-kaurenoids with selective anticancer properties.
- Compound 2 is a promising candidate for breast cancer research.
- Compounds 3 and 4 warrant further investigation for prostate cancer therapy.
- This study highlights the potential of Annona senegalensis as a source of novel anticancer drugs.